201 related articles for article (PubMed ID: 25337214)
1. Immunohistochemical expression of CD117 and vascular endothelial growth factor in retinoblastoma: possible targets of new therapies.
Youssef NS; Said AM
Int J Clin Exp Pathol; 2014; 7(9):5725-37. PubMed ID: 25337214
[TBL] [Abstract][Full Text] [Related]
2. Expression of C-kit in retinoblastoma: a potential therapeutic target.
Barry RJ; de Moura LR; Marshall JC; Fernandes BF; Orellana ME; Antecka E; Martins C; Burnier MN
Br J Ophthalmol; 2007 Nov; 91(11):1532-6. PubMed ID: 17591671
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of high-risk features of primary enucleation of patients with retinoblastoma in a tertiary center of a developing country in the era of intra-arterial chemotherapy.
Dikkaya F; Sarıcı AM; Erbek F; Celkan T; Mangan MS; Aydın Ö; Demirkesen C; Pazarlı H
Int Ophthalmol; 2018 Feb; 38(1):151-156. PubMed ID: 28058667
[TBL] [Abstract][Full Text] [Related]
4. Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours.
Stitt AW; Simpson DA; Boocock C; Gardiner TA; Murphy GM; Archer DB
J Pathol; 1998 Nov; 186(3):306-12. PubMed ID: 10211121
[TBL] [Abstract][Full Text] [Related]
5. Extensively necrotic retinoblastoma is associated with high-risk prognostic factors.
Chong EM; Coffee RE; Chintagumpala M; Hurwitz RL; Hurwitz MY; Chévez-Barrios P
Arch Pathol Lab Med; 2006 Nov; 130(11):1669-72. PubMed ID: 17076529
[TBL] [Abstract][Full Text] [Related]
6. Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study.
Chévez-Barrios P; Eagle RC; Krailo M; Piao J; Albert DM; Gao Y; Vemuganti G; Ali MJ; Khetan V; Honavar SG; O'Brien J; Leahey AM; Matthay K; Meadows A; Chintagumpala M
J Clin Oncol; 2019 Nov; 37(31):2883-2891. PubMed ID: 31539297
[TBL] [Abstract][Full Text] [Related]
7. Stem cell markers: ABCG2 and MCM2 expression in retinoblastoma.
Mohan A; Kandalam M; Ramkumar HL; Gopal L; Krishnakumar S
Br J Ophthalmol; 2006 Jul; 90(7):889-93. PubMed ID: 16556617
[TBL] [Abstract][Full Text] [Related]
8. Expression of Angiogenic Factors in Invasive Retinoblastoma Tumors Is Associated With Increase in Tumor Cells Expressing Stem Cell Marker Sox2.
Garcia JR; Gombos DS; Prospero CM; Ganapathy A; Penland RL; Chévez-Barrios P
Arch Pathol Lab Med; 2015 Dec; 139(12):1531-8. PubMed ID: 26619025
[TBL] [Abstract][Full Text] [Related]
9. Delayed Enucleation With Neoadjuvant Chemotherapy in Advanced Intraocular Unilateral Retinoblastoma: AHOPCA II, a Prospective, Multi-Institutional Protocol in Central America.
Luna-Fineman S; Chantada G; Alejos A; Amador G; Barnoya M; Castellanos ME; Fu L; Fuentes-Alabi S; Girón V; Goenz MA; Maldonado C; Méndez G; Morales RA; Ortiz R; Sanchez G; Wilson M; Rodríguez-Galindo C
J Clin Oncol; 2019 Nov; 37(31):2875-2882. PubMed ID: 31536438
[TBL] [Abstract][Full Text] [Related]
10. Leucine-Rich α-2-Glycoprotein-1 (LRG-1) Expression in Retinoblastoma.
Amer R; Tiosano L; Pe'er J
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):685-692. PubMed ID: 29392314
[TBL] [Abstract][Full Text] [Related]
11. Outcome of children with retinoblastoma and isolated choroidal invasion.
Bosaleh A; Sampor C; Solernou V; Fandiño A; Domínguez J; de Dávila MT; Chantada GL
Arch Ophthalmol; 2012 Jun; 130(6):724-9. PubMed ID: 22801832
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical determination of HER-2/neu, c-Kit (CD117), and vascular endothelial growth factor (VEGF) overexpression in malignant melanoma.
Potti A; Moazzam N; Langness E; Sholes K; Tendulkar K; Koch M; Kargas S
J Cancer Res Clin Oncol; 2004 Feb; 130(2):80-6. PubMed ID: 14634801
[TBL] [Abstract][Full Text] [Related]
13. A study of pathologic risk factors in postchemoreduced, enucleated specimens of advanced retinoblastomas in a developing country.
Suryawanshi P; Ramadwar M; Dikshit R; Kane SV; Kurkure P; Banavali S; Viswanathan S
Arch Pathol Lab Med; 2011 Aug; 135(8):1017-23. PubMed ID: 21809993
[TBL] [Abstract][Full Text] [Related]
14. Histopathological features and P-glycoprotein expression in retinoblastoma.
Filho JP; Correa ZM; Odashiro AN; Coutinho AB; Martins MC; Erwenne CM; Burnier MN
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3478-83. PubMed ID: 16186322
[TBL] [Abstract][Full Text] [Related]
15. Relationship between histopathological features of chemotherapy treated retinoblastoma and P-glycoprotein expression.
Souza Filho JP; Martins MC; Caissie AL; Torres VL; Fernandes LH; Erwenne CM; Burnier MN
Clin Exp Ophthalmol; 2005 Jun; 33(3):279-84. PubMed ID: 15932532
[TBL] [Abstract][Full Text] [Related]
16. Multidrug resistant proteins: P-glycoprotein and lung resistance protein expression in retinoblastoma.
Krishnakumar S; Mallikarjuna K; Desai N; Muthialu A; Venkatesan N; Sundaram A; Khetan V; Shanmugam MP
Br J Ophthalmol; 2004 Dec; 88(12):1521-6. PubMed ID: 15548804
[TBL] [Abstract][Full Text] [Related]
17. The impact of growth patterns of retinoblastoma (endophytic, exophytic, and mixed patterns).
Nawaiseh I; Al-Hussaini M; Alhamwi A; Meyar M; Sultan I; Alrawashdeh K; Jaradat I; Yousef YA
Turk Patoloji Derg; 2015; 31(1):45-50. PubMed ID: 25301049
[TBL] [Abstract][Full Text] [Related]
18. Management of advanced uni- or bilateral retinoblastoma with macroscopic optic nerve invasion.
Choucair ML; Brisse HJ; Fréneaux P; Desjardins L; Dorfmüller G; Puget S; Dendale R; Chevrier M; Doz F; Lumbroso-Le Rouic L; Aerts I
Pediatr Blood Cancer; 2020 Jan; 67(1):e27998. PubMed ID: 31571399
[TBL] [Abstract][Full Text] [Related]
19. [Histopathologic findings in retinoblastoma].
de Souza Filho JP; Martins MC; Torres VL; Dias AB; Lowen MS; Pires LA; Erwenne CM
Arq Bras Oftalmol; 2005; 68(3):327-31. PubMed ID: 16059563
[TBL] [Abstract][Full Text] [Related]
20. mTOR, VEGF, PDGFR, and c-kit signaling pathway activation in Kaposi sarcoma.
Kerr DA; Busarla SVP; Gimbel DC; Sohani AR; Nazarian RM
Hum Pathol; 2017 Jul; 65():157-165. PubMed ID: 28506734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
